Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Chemicals and Drugs (2)
- Diseases (2)
- Health and Medical Administration (2)
- Investigative Techniques (2)
- Amino Acids, Peptides, and Proteins (1)
-
- Bioethics and Medical Ethics (1)
- Cardiology (1)
- Diagnosis (1)
- Health Services Administration (1)
- Laboratory and Basic Science Research (1)
- Life Sciences (1)
- Medical Specialties (1)
- Medicine and Health (1)
- Neoplasms (1)
- Other Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Pathological Conditions, Signs and Symptoms (1)
- Pharmaceutical Preparations (1)
- Public Health (1)
- Social and Behavioral Sciences (1)
- Sociology (1)
- Therapeutics (1)
- Keyword
-
- AVUS (1)
- Biomarkers (1)
- Carcinoma (1)
- Cardiac fibrosis markers (1)
- Galectin-3 (1)
-
- Health Disparate Populations (1)
- Heart Failure (1)
- Hepatocellular (1)
- Machine Learning (1)
- Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry (1)
- Mice (1)
- NT-proBNP (1)
- Pain Management (1)
- Pain Perception (1)
- Preserved Ejection Fraction (1)
- Risk Assessment (1)
- Serum Markers (1)
- Somatoform Disorders (1)
- TMAO (1)
- Therapeutic ultrasound (1)
- Trimethylamine N-oxide (1)
- Women (1)
Articles 1 - 3 of 3
Full-Text Articles in Medical Biotechnology
Advancing Risk Stratification In Hfpef: Unveiling The Potential Of Cardiac Fibrosis Markers For Early Diagnosis And Enhanced Patient Outcomes, Mariam Abdeen
Rowan-Virtua Research Day
Heart failure with preserved ejection fraction (HFpEF) challenges clinicians due to its diverse presentation and limitations in traditional diagnostic criteria. This study delves into the potential of cardiac fibrosis markers like galectin-3, NT-proBNP, and trimethylamine N-oxide (TMAO) to enhance diagnostic precision and patient outcomes in HFpEF. A systematic review of sixteen relevant studies revealed that these biomarkers offer promise for early detection and improved risk assessment. For instance, TMAO indicates systemic implications of HFpEF, while galectin-3 shows predictive value across heart failure types. Additionally, machine-learning models incorporating multiple biomarkers predict significant risk of adverse outcomes. Despite these advances, challenges like …
Maldi-Tof Ms Based Proteomic Fingerprinting Of Total Serum Plasma For Somatic Pain Syndromes, Isaiah Pinkerton, Venkateswar Venkataraman
Maldi-Tof Ms Based Proteomic Fingerprinting Of Total Serum Plasma For Somatic Pain Syndromes, Isaiah Pinkerton, Venkateswar Venkataraman
Rowan-Virtua Research Day
There are racial and ethnic disparities regarding pain management within the United States, and that disproportionately affects women of color. There is also a fundamental lack of information regarding the biological mechanism by which pain sensitization and perception occurs, and how it could be affected by both neurologic and somatic pain syndromes.
Methods: Research was performed on principal electronic scientific databases including Google Scholar, PubMed, and Embase with search terms “MALDI-TOF”, “ESI-MS”, “Pain”, and “Biomarkers”, as well as other modifiers to narrow the literature search.
Results: Studies on comparison between MALDI-TOF and other traditional analysis platforms, including Electrospray Ionization (ESI-MS), …
Novel Technology Enables Diagnostic Ultrasound Machine To Treat Hepatocellular Carcinoma In Mice, Ryan Morrison, Mrigendra B. Karmacharya, Chandra M. Sehgal
Novel Technology Enables Diagnostic Ultrasound Machine To Treat Hepatocellular Carcinoma In Mice, Ryan Morrison, Mrigendra B. Karmacharya, Chandra M. Sehgal
Rowan-Virtua Research Day
An off-the-shelf diagnostic transducer (ULTRASONIX C5-2) was modified with custom-built circuitry to enable the transducer to produce therapeutic ultrasound in order to ablate hepatocellular carcinomas grown in immunodeficient athymic nude mice (25-35 g; Charles River Laboratories, Wilmington, MA, USA). The therapeutic antivascular ultrasound (AVUS) produced by the off-the-shelf abdominal transducer was unfocused, continuous 2.8MHz ultrasound targeting contrast-enhancing perflutren lipid microbubbles within tumor vasculature. Previous research with a dedicated physiotherapy ultrasound machine (D150 Plus, Dynatronics Corp., Salt Lake City, UT, USA) targeting similar hepatocellular carcinomas showed disrupted tumor neovasculature and irreparable dilation of tumor capillaries with subsequent intercellular edema and hemorrhage.1-3 …